Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial

• Main Authors: Xavier Sáez-Llorens (Author), Stella Rowley (Author), Digna Wong (Author), Mirna Rodríguez (Author), Arlene Calvo (Author), Marisol Troitiño (Author), Albino Salas (Author), Vielka Vega (Author), Maria Mercedes Castrejón (Author), Patricia Lommel (Author), Thierry G. Pascal (Author), William P. Hausdorff (Author), Dorota Borys (Author), Javier Ruiz-Guiñazú (Author), Eduardo Ortega-Barría (Author), Juan Pablo Yarzabal (Author), Lode Schuerman (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We previously reported 10-valent pneumococcal non-typeable Haemophilus influenzae (NTHi) protein D conjugate vaccine (PHiD-CV) efficacy in a double-blind randomized trial (ClinicalTrials.gov: NCT00466947) against various diseases, including acute otitis media (AOM). Here, we provide further analyses...